FR2325377A1 - NEW N-ARYL-N- (1-L-4-PIPERIDINYL) -ARYLACETAMIDES - Google Patents

NEW N-ARYL-N- (1-L-4-PIPERIDINYL) -ARYLACETAMIDES

Info

Publication number
FR2325377A1
FR2325377A1 FR7627870A FR7627870A FR2325377A1 FR 2325377 A1 FR2325377 A1 FR 2325377A1 FR 7627870 A FR7627870 A FR 7627870A FR 7627870 A FR7627870 A FR 7627870A FR 2325377 A1 FR2325377 A1 FR 2325377A1
Authority
FR
France
Prior art keywords
arylacetamides
piperidinyl
aryl
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7627870A
Other languages
French (fr)
Other versions
FR2325377B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of FR2325377A1 publication Critical patent/FR2325377A1/en
Application granted granted Critical
Publication of FR2325377B1 publication Critical patent/FR2325377B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7627870A 1975-09-23 1976-09-16 NEW N-ARYL-N- (1-L-4-PIPERIDINYL) -ARYLACETAMIDES Granted FR2325377A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61513175A 1975-09-23 1975-09-23
US71375676A 1976-08-12 1976-08-12

Publications (2)

Publication Number Publication Date
FR2325377A1 true FR2325377A1 (en) 1977-04-22
FR2325377B1 FR2325377B1 (en) 1980-04-18

Family

ID=27087421

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7627870A Granted FR2325377A1 (en) 1975-09-23 1976-09-16 NEW N-ARYL-N- (1-L-4-PIPERIDINYL) -ARYLACETAMIDES

Country Status (29)

Country Link
JP (1) JPS6016417B2 (en)
AT (1) AT363935B (en)
AU (1) AU510029B2 (en)
BG (1) BG27543A3 (en)
CA (1) CA1068271A (en)
CH (1) CH628623A5 (en)
CS (1) CS222663B2 (en)
DE (1) DE2642856A1 (en)
DK (1) DK150478C (en)
ES (1) ES451768A1 (en)
FI (1) FI61482C (en)
FR (1) FR2325377A1 (en)
GB (1) GB1539473A (en)
GR (1) GR58469B (en)
HU (1) HU172964B (en)
IE (1) IE43802B1 (en)
IL (1) IL50522A (en)
IT (1) IT1073893B (en)
LU (1) LU75837A1 (en)
NL (1) NL187267C (en)
NO (1) NO147672C (en)
NZ (1) NZ181972A (en)
PH (1) PH12497A (en)
PL (2) PL117323B1 (en)
PT (1) PT65631B (en)
RO (1) RO70079A (en)
SE (1) SE427839B (en)
SU (1) SU747424A3 (en)
YU (1) YU39973B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA765684B (en) * 1975-09-23 1978-04-26 Janssen Pharmaceutica Nv Novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS62260786A (en) * 1986-05-08 1987-11-13 株式会社ヘキトク Line system for manufacturing smoked roof tile
JO2769B1 (en) 2005-10-26 2014-03-15 جانسين فارماسوتيكا ان. في Fast Dissociting Dopamine 2 Receptor Antagonists
JO2642B1 (en) 2006-12-08 2012-06-17 جانسين فارماسوتيكا ان. في Fast Dissociating Dopamine 2 Receptor Antagonists
JO2849B1 (en) 2007-02-13 2015-03-15 جانسين فارماسوتيكا ان. في Fast -Dissociating Dopamine 2 Receptor Antagonists
WO2008128994A1 (en) * 2007-04-23 2008-10-30 Janssen Pharmaceutica N.V. Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
MX2009011415A (en) 2007-04-23 2009-11-05 Janssen Pharmaceutica Nv 4-alkoxypyridazine derivatives as fast dissociating dopamine 2 receptor antagonists.
CA2682671C (en) 2007-04-23 2015-11-17 Janssen Pharmaceutica N.V. Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists
JP5417439B2 (en) 2008-07-03 2014-02-12 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Substituted 6- (1-piperazinyl) -pyridazines as 5-HT6 receptor antagonists
CN102171189B (en) 2008-07-31 2013-11-20 詹森药业有限公司 Piperazin-1-yl-trifluoromethyl-substituted-pyridines as fast dissociating dopamine 2 receptor antagonists

Also Published As

Publication number Publication date
SE427839B (en) 1983-05-09
IL50522A0 (en) 1976-11-30
NL187267B (en) 1991-03-01
GR58469B (en) 1977-10-14
PL117323B1 (en) 1981-07-31
AU1787876A (en) 1978-03-23
DK150478B (en) 1987-03-09
JPS6016417B2 (en) 1985-04-25
PL192578A1 (en) 1979-02-26
BG27543A3 (en) 1979-11-12
JPS5239683A (en) 1977-03-28
RO70079A (en) 1982-10-26
HU172964B (en) 1979-01-28
PT65631A (en) 1976-10-01
FI762698A (en) 1977-03-24
ATA702976A (en) 1981-02-15
DK150478C (en) 1987-10-05
AU510029B2 (en) 1980-06-05
NL7610513A (en) 1977-03-25
NO147672B (en) 1983-02-14
PH12497A (en) 1979-04-05
LU75837A1 (en) 1977-05-04
NO763054L (en) 1977-03-24
FR2325377B1 (en) 1980-04-18
IL50522A (en) 1979-09-30
YU233676A (en) 1983-01-21
FI61482B (en) 1982-04-30
CS222663B2 (en) 1983-07-29
ES451768A1 (en) 1978-05-01
DE2642856A1 (en) 1977-03-24
SE7610501L (en) 1977-03-24
DE2642856C2 (en) 1990-06-21
IE43802L (en) 1977-03-23
NL187267C (en) 1991-08-01
IT1073893B (en) 1985-04-17
YU39973B (en) 1985-06-30
DK427876A (en) 1977-03-24
CH628623A5 (en) 1982-03-15
GB1539473A (en) 1979-01-31
PT65631B (en) 1978-07-05
AT363935B (en) 1981-09-10
SU747424A3 (en) 1980-07-23
NO147672C (en) 1983-05-25
IE43802B1 (en) 1981-06-03
CA1068271A (en) 1979-12-18
NZ181972A (en) 1978-07-28
FI61482C (en) 1982-08-10

Similar Documents

Publication Publication Date Title
FR2300076A1 (en) NEW
FR2311815A1 (en) NEW POLYESTERIMIDE-POLYESTER MIXTURES
FR2300081A1 (en) NEW D
FR2327787A1 (en) NEW ANTIHYPERTENSEATING AGENTS
FR2300551A2 (en) NEW
FR2300077A1 (en) NEW ETHERS
BE844169A (en) NEW STEROIDS
FR2297216A1 (en) NEW NUCLEOSIDES
FR2302323A1 (en) NEW POLYSILOXANE-POLYXYALK COPOLYMERS
FR2325377A1 (en) NEW N-ARYL-N- (1-L-4-PIPERIDINYL) -ARYLACETAMIDES
FR2298330A2 (en) NEW D
FR2338262A1 (en) NEW DERI
FR2300226A1 (en) IMPROVEMENTS
FR2315937A1 (en) NEW SELENIES STEROIDS
FR2319358A1 (en) NEW HOMOPHTHALIMIDES
BE849587A (en) NEW N-SUBSTITUTE SPIROACTAMES
FR2299188A1 (en) IMPROVEMENTS
FR2299028A1 (en) NEW
FR2301243A1 (en) NEW
FR2297838A1 (en) NEW DERI
AT346618B (en) MICROSCOPOCULAR
FR2298542A1 (en) NEW COMPL
MC1121A1 (en) NEW D-HOMOSTEROIDS
SE7612530L (en) SEVERAL PHENOLESHAMERS
JPS51100390A (en) SET SUDANTOISHI

Legal Events

Date Code Title Description
ST Notification of lapse